Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies

被引：0
|
作者：
Michael Rainone
Tanya Siddiqi
机构：
[1] City of Hope,Department of Hematology and Medical Oncology
[2] City of Hope,Department of Hematology & Hematopoietic Cell Transplantation
来源：
Current Hematologic Malignancy Reports | 2022年 / 17卷
关键词：
Chronic lymphocytic leukemia; Small lymphocytic lymphoma; Ibrutinib; Acalabrutinib; Venetoclax; Chimeric antigen receptor (CAR) T cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：39 / 45
页数：6
相关论文
共 50 条
  • [1] Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies
    Rainone, Michael
    Siddiqi, Tanya
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2022, 17 (01) : 39 - 45
  • [2] Optimizing Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Mato, Anthony
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (5.5): : 581 - 583
  • [3] Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukemia
    Eyre, Toby A.
    Lamanna, Nicole
    Roeker, Lindsey E.
    Ujjani, Chaitra S.
    Hill, Brian T.
    Barr, Paul M.
    Lansigan, Erick
    Cheson, Bruce D.
    Yazdy, Maryam
    Allan, John N.
    Rhodes, Joanna
    Schuster, Stephen J.
    Nabhan, Chadi
    Skarbnik, Alan
    Leslie, Lorie
    Islam, Prioty
    Whitaker, Katherine
    Coombs, Catherine C.
    Tuncer, Hande H.
    Pagel, John M.
    Jacobs, Ryan
    Winter, Allison M.
    Bailey, Neil
    Sitlinger, Andrea
    Schuh, Anna H.
    Follows, George
    Fox, Christopher P.
    Brander, Danielle M.
    Shadman, Mazyar
    Mato, Anthony R.
    HAEMATOLOGICA, 2021, 106 (01) : 284 - 287
  • [4] ALPINE: zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma
    Hillmen, Peter
    Brown, Jennifer R.
    Eichhorst, Barbara F.
    Lamanna, Nicole
    O'Brien, Susan M.
    Qiu, Lugui
    Salmi, Tommi
    Hilger, James
    Wu, Kenneth
    Cohen, Aileen
    Huang, Jane
    Tam, Constantine S.
    FUTURE ONCOLOGY, 2020, 16 (10) : 517 - 523
  • [5] Current Treatment Options in Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: a Review
    Islam, Prioty
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (09) : 1259 - 1273
  • [6] Sequential ofatumumab and lenalidomide for the treatment of relapsed and refractory chronic lymphocytic leukemia and small lymphocytic lymphoma
    Costa, Luciano J.
    Fanning, Suzanne R.
    Stephenson, Joe, Jr.
    Afrin, Lawrence B.
    Kistner-Griffin, Emily
    Bentz, Tricia A.
    Stuart, Robert K.
    LEUKEMIA & LYMPHOMA, 2015, 56 (03) : 645 - 649
  • [7] Current Treatment Options in Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: a Review
    Prioty Islam
    Current Treatment Options in Oncology, 2023, 24 : 1259 - 1273
  • [8] Management of relapsed/refractory Chronic Lymphocytic Leukemia
    Woyach, Jennifer A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S11 - S18
  • [9] Management of relapsed/refractory chronic lymphocytic leukemia
    Tomowiak, Cecile
    HEMATOLOGIE, 2024, 30 : 19 - 27
  • [10] Management of elderly patients with chronic lymphocytic leukemia in the era of targeted therapies
    Ysebaert, Loic
    Feugier, Pierre
    Michallet, Anne-Sophie
    CURRENT OPINION IN ONCOLOGY, 2015, 27 (05) : 365 - 370
12345